Fucoidan extracts ameliorate acute colitis

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Lean, Qi Ying ^a,b   Eri, Rajaraman D ^a   Fitton, J Helen ^c   Patel, Rahul P ^a   Gueven, Nuri ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c Marinova Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEPYROGENATED FUCOIDAN; DEXTRAN SULFATE; EOTAXIN; FUCOIDAN POLYPHENOL COMPLEX; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; POLYSACCHARIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; FUCOIDIN; PLANT EXTRACT; POLYPHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL INFILTRATION; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DRUG EFFECT; EDEMA; GOBLET CELL; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; INTESTINE CRYPT; MALE; MOUSE; NONHUMAN; RECTUM HEMORRHAGE; SPLEEN WEIGHT; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; FUCUS; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; SPLEEN;

MUS; PHAEOPHYCEAE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FUCUS; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PLANT EXTRACTS; POLYPHENOLS; POLYSACCHARIDES; SPLEEN;

EID: 84939184299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128453     Document Type: Article

References (53)

1. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140: 1785-1794. doi: 10.1053/j.gastro.2011.01.055 PMID: 21530745
2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012; 380: 1606-1619. doi: 10.1016/S0140-6736(12)60150-0 PMID: 22914296
3. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012; 380: 1590-1605. doi: 10.1016/S0140-6736(12)60026-9 PMID: 22914295
4. Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther. 2011; 5: 185-210. doi: 10.2147/DDDT.S11290 PMID: 21552489
5. Akobeng AA, Sandborn WJ, Bickston SJ, Chande N, Shackelton LM, Nelson S, et al. Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us? Inflamm Bowel Dis. 2014; 20: 2132-2141. doi: 10.1097/MIB.0000000000000218 PMID: 25299543
6. Park KT, Bass D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: A review. Inflamm Bowel Dis. 2011; 17: 1603-1609. doi: 10.1002/ibd.21488 PMID: 21053357
7. Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, et al. Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis. 2008; 2: 219-225. doi: 10.1016/j.crohns.2008.03.004 PMID: 21172214
8. Peyrin-Biroulet L, Deltenre P, De Suray N, Branche J, Sandborn WJ, Colombel JF. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2008; 6: 644-653. doi: 10.1016/j.cgh.2008.03.014 PMID: 18550004
9. Ben-Horin S, Chowers Y. Review article: loss of response to anti-TNF treatments in Crohn's disease. Aliment Pharmacol Ther. 2011; 33: 987-995. doi: 10.1111/j.1365-2036.2011.04612.x PMID: 21366636
10. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013; 7: 1341-1356. doi: 10.2147/DDDT.S40107 PMID: 24250223
11. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007; 2: 541-546. PMID: 17406617
12. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. BioMed Res Int. 2012; 2012.
13. Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014; 104: 15.25. 11-15.25. 14.
14. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98: 694-702. PMID: 1688816
15. Rose W, Sakamoto K, Leifer C. Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases. BMC Immunol. 2012; 13: 41. doi: 10.1186/1471-2172-13-41 PMID: 22853702
16. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2008; 15: 341-352.
17. Melgar S, Karlsson L, Rehnström E, Karlsson A, Utkovic H, Jansson L, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008; 8: 836-844. doi: 10.1016/j.intimp.2008.01.036 PMID: 18442787
18. Fitton JH. Therapies from fucoidan; multifunctional marine polymers. Mar Drugs. 2011; 9: 1731-1760. doi: 10.3390/md9101731 PMID: 22072995
19. Ale MT, Mikkelsen JD, Meyer AS. Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds. Mar Drugs. 2011; 9: 2106-2130. doi: 10.3390/md9102106 PMID: 22073012
20. Zhang XW, Liu Q, Thorlacius H. Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis. Scand J Gastroenterol. 2001; 36: 270-275. PMID: 11305514
21. Matsumoto S, Nagaoka M, Hara T, Kimura-Takagi I, Mistuyama K, Ueyama S. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells. Clin Exp Immunol. 2004; 136: 432-439. PMID: 15147344
22. Koetzner L, Grover G, Boulet J, Jacoby HI. Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat. Dig Dis Sci. 2010; 55: 1278-1285. doi: 10.1007/s10620-009-0848-7 PMID: 19513840
23. Choi JI, Raghavendran HR, Sung NY, Kim JH, Chun BS, Ahn DH, et al. Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem Biol Interact. 2010; 183: 249-254. doi: 10.1016/j.cbi.2009.09.015 PMID: 19788892
24. Cai J, Kim TS, Jang JY, Kim J, Shin K, Lee SP, et al. In vitro and in vivo anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract. Lab Anim Res. 2014; 30: 28-34. doi: 10.5625/lar.2014.30.1.28 PMID: 24707302
25. Lutay N, Nilsson I, Wadström T, Ljungh Å. Effect of heparin, fucoidan and other polysaccharides on adhesion of enterohepatic helicobacter species to murine macrophages. Appl Biochem Biotechnol. 2011; 164: 1-9. doi: 10.1007/s12010-010-9109-7 PMID: 21088929
26. Juffrie M, Rosalina I, Damayanti W, Djumhana A, Ahmad H. The efficacy of fucoidan on gastric ulcer. Indones J Biotechnol. 2011; 11: 908-913.
27. Heitz FD, Erb M, Anklin C, Robay D, Pernet V, Gueven N. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy. PLoS One. 2012; 7: e45182. doi: 10.1371/journal.pone.0045182 PMID: 23028832
28. Eri R, McGuckin M, Wadley R. T cell transfer model of colitis: A great tool to assess the contribution of T cells in chronic intestinal inflammation. In: Ashman RB, editor. Leucocytes. Methods in Molecular Biology. 844: Humana Press; 2012. p. 261-275. doi: 10.1007/978-1-61779-527-5-19 PMID: 22262449
29. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang J-P, Brown EM, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014; 156: 1045-1059. doi: 10.1016/j.cell.2014.01.026 PMID: 24581500
30. Zheng B, van Bergenhenegouwen J, Overbeek S, van de Kant HJ, Garssen J, Folkerts G, et al. Bifidobacterium breve Attenuates Murine Dextran Sodium Sulfate-Induced Colitis and Increases Regulatory T Cell Responses. PLoS One. 2014; 9: e95441. doi: 10.1371/journal.pone.0095441 PMID: 24787575
31. Kuznetsova TA, Besednova NN, Somova LM, Plekhova NG. Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia. Mar Drugs. 2014; 12: 886-898. doi: 10.3390/md12020886 PMID: 24492521
32. Lee S-H, Ko C-I, Jee Y, Jeong Y, Kim M, Kim J-S, et al. Anti-inflammatory effect of fucoidan extracted from Ecklonia cava in zebrafish model. Carbohydr Polym. 2013; 92: 84-89. doi: 10.1016/j.carbpol.2012.09.066 PMID: 23218269
33. Cui YQ, Jia YJ, Zhang T, Zhang QB, Wang XM. Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci Ther. 2012; 18: 827-833. doi: 10.1111/j.1755-5949.2012.00372.x PMID: 23006515
34. Kim KJ, Yoon KY, Lee BY. Low molecular weight fucoidan from the sporophyll of Undaria pinnatifida suppresses inflammation by promoting the inhibition of mitogen-activated protein kinases and oxidative stress in RAW264.7 cells. Fitoterapia. 2012; 83: 1628-1635. doi: 10.1016/j.fitote.2012.09.014 PMID: 23006539
35. Mizuno M, Nishitani Y, Hashimoto T, Kanazawa K. Different suppressive effects of fucoidan and lentinan on IL-8 mRNA expression in in vitro gut inflammation. Biosci Biotechnol Biochem. 2009; 73: 2324-2325. PMID: 19809164
36. Carvalho AC, Sousa RB, Franco AX, Costa JV, Neves LM, Ribeiro RA, et al. Protective effects of fucoidan, a P- and L-selectin inhibitor, in murine acute pancreatitis. Pancreas. 2014; 43: 82-87. doi: 10.1097/MPA.0b013e3182a63b9d PMID: 24177139
37. Maillard MH, Snapper SB. Cytokines and chemokines in mucosal homeostasis. In: Targan SR, Shanahan F, Karp LC, editors. Inflammatory Bowel Disease: Wiley-Blackwell; 2010. p. 119-156.
38. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 14: 329-342. doi: 10.1038/nri3661 PMID: 24751956
39. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol. 2003; 199: 28-35. PMID: 12474223
40. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol. 1999; 34: 66-74. PMID: 10204613
41. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014; 20: 6-21. doi: 10.3748/wjg.v20.i1.6 PMID: 24415853
42. Heinsbroek SE, Gordon S. The role of macrophages in inflammatory bowel diseases. Expert Rev Mol Med. 2009; 11: e14. doi: 10.1017/S1462399409001069 PMID: 19439108
43. Zhu W, Yu J, Nie Y, Shi X, Liu Y, Li F, et al. Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunol Invest. 2014; 43: 638-652. doi: 10.3109/08820139.2014.909456 PMID: 24921428
44. Shintani N, Nakajima T, Sugiura M, Murakami K, Nakamura N, Kagitani Y, et al. Proliferative effect of dextran sulfate sodium (DSS)-pulsed macrophages on T cells from mice with DSS-induced colitis and inhibition of effect by IgG. Scand J Immunol. 1997; 46: 581-586. PMID: 9420621
45. Li C, Gao Y, Xing Y, Zhu H, Shen J, Tian J. Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia-reperfusion injury in rats via regulating the inflammation response. Food Chem Toxicol. 2011; 49: 2090-2095. doi: 10.1016/j.fct.2011.05.022 PMID: 21645579
46. Lee SH, Ko CI, Ahn G, You S, Kim JS, Heu MS, et al. Molecular characteristics and anti-inflammatory activity of the fucoidan extracted from Ecklonia cava. Carbohydr Polym. 2012; 89: 599-606. doi: 10.1016/j.carbpol.2012.03.056 PMID: 24750764
47. Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, Mizuno M. In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem Biophys Res Commun. 2008; 374: 565-569. doi: 10.1016/j.bbrc.2008.07.063 PMID: 18647595
48. Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007; 17: 541-552. PMID: 17296677
49. Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, et al. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. Biochem Pharmacol. 2011; 81: 233-243. doi: 10.1016/j.bcp.2010.09.021 PMID: 20887714
50. Senni K, Gueniche F, Foucault-Bertaud A, Igondjo-Tchen S, Fioretti F, Colliec-Jouault S, et al. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch Biochem Biophys. 2006; 445: 56-64. PMID: 16364234
51. Jin J-O, Zhang W, Du J-Y, Wong K-W, Oda T, Yu Q. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses. PLoS One. 2014; 9: e99396. doi: 10.1371/journal.pone.0099396 PMID: 24911024
52. Chung HJ, Jeun J, Houng SJ, Jun HJ, Kweon DK, Lee SJ. Toxicological evaluation of fucoidan from Undaria pinnatifida in vitro and in vivo. Phytother Res. 2010; 24: 1078-1083. doi: 10.1002/ptr.3138 PMID: 20578121
53. Kim KJ, Lee OH, Lee HH, Lee BY. A 4-week repeated oral dose toxicity study of fucoidan from the Sporophyll of Undaria pinnatifida in Sprague-Dawley rats. Toxicology. 2010; 267: 154-158. doi: 10.1016/j.tox.2009.11.007 PMID: 19903507